@FiercePharma: Our latest ranking: 10 Largest Settlements and Judgments. Includes those big state deals. More | Follow @FiercePharma
> Pfizer's ($PFE) cancer drug Inlyta fell short in a study in kidney cancer patients, but company officials said it was close, and sub-populations may merit further study. Report
> Sanofi ($SNY) is trying to recruit high-tech companies to develop an IT hub on the site of its factory in Dagenham, England, which is slated for closure as part of a global cost-cutting effort. Report
> Federal prosecutors raided New England Compounding Center, the pharmacy tied to a meningitis outbreak. Report
> Novo Nordisk ($NVO) has contributed more money to U.S. candidates this election cycle--about $176,000--than any other contributor from Denmark. Report
> Richard Roberts, CEO of URL Pharmaceuticals until it was sold to Takeda in June, funded a new political group to support Florida Rep. Allen West; he contributed $1 million to the effort. Report
> The European Union's health commissioner stepped down amid corruption charges related to tobacco products. Report
Biotech News
@FierceBiotech: Scientists produced stem cells from cadaver scalp tissue. Item | Follow @FierceBiotech
@JohnCFierce: Looks like Samsung is getting a taste of just how devilishly hard it can be to develop drugs. More | Follow @JohnCFierce
@RyanMFierce: Charles River is touting a 3-year strategic deal with AstraZeneca, which is outsourcing across the globe. More | Follow @RyanMFierce
> Cebix gains $31M, new CEO as it preps for PhIIb diabetes study. Story
> FDA advisers back NPS Pharma's orphan bowel drug. Article
@FierceMedDev: The FDA has slapped its most serious label on Accutron's voluntary flowmeter recall. More | Follow @FierceMedDev
@MarkHFierce: New device company Cibiem launches with $10M series A. More | Follow @MarkHFierce
@DamianFierce: AstraZeneca's inked a deal with another CRO, picking Charles River to help speed along its pipeline. More | Follow @DamianFierce
> Quest lowers outlook after Q3 profit drop. Story
> For some, Intuitive Surgical's Q3 20% revenue jump isn't enough. Article
> Analyst: China is primed for a medical device boom. News
Biomarkers News
> Gene variants increase bipolar risk. Article
> Protein marker could cut cost of cancer screening. More
> Gene variant in donated kidneys could mark survival. Report
> Endocyte uses vitamin receptor to tag lung cancer. Story
Drug Delivery News
> Simple anti-HIV vaginal ring delivers three months of protection. Story
> Over the moon? NASA develops motion sickness nasal spray. Item
> Why shape matters in gene delivery. More
> Hiding in plain sight: Using red blood cell proteins to deliver drugs. Article
> Unilife announces new eye delivery platforms. News
And Finally... FDA warned Avon Products about claims made on certain antiwrinkle products, a month after going after L'Oréal's Lancôme unit for similar reasons. Report